Pharmacogenomic data submissions to the FDA: clinical pharmacology case studies.
作者信息
Ruaño Gualberto, Collins Jerry M, Dorner Andrew J, Wang Sue-Jane, Guerciolini Roberto, Huang Shiew-Mei
机构信息
Genomas LLC, New Haven, CT, USA.
出版信息
Pharmacogenomics. 2004 Jul;5(5):513-7. doi: 10.1517/14622416.5.5.513.
PMID:15212588
Abstract
摘要
相似文献
1
Pharmacogenomic data submissions to the FDA: clinical pharmacology case studies.向美国食品药品监督管理局提交的药物基因组学数据：临床药理学案例研究
Pharmacogenomics. 2004 Jul;5(5):513-7. doi: 10.1517/14622416.5.5.513.
2
Pharmacogenomic data submissions to the FDA: clinical case studies.向美国食品药品监督管理局提交的药物基因组学数据：临床案例研究
Pharmacogenomics. 2004 Jul;5(5):519-24. doi: 10.1517/14622416.5.5.519.
3
Pharmacogenomic data submissions to the FDA: non-clinical case studies.向美国食品药品监督管理局提交的药物基因组学数据：非临床案例研究
Pharmacogenomics. 2004 Jul;5(5):507-11. doi: 10.1517/14622416.5.5.507.
4
Pharmacogenomic data: FDA voluntary and required submission guidance.
Pharmacogenomics. 2004 Jul;5(5):503-5. doi: 10.1517/14622416.5.5.503.
5
Clinical pharmacology and the catalysis of regulatory science: opportunities for the advancement of drug development and evaluation.临床药理学与监管科学的催化：推进药物研发和评估的机遇。
Clin Pharmacol Ther. 2013 Jun;93(6):515-25. doi: 10.1038/clpt.2013.32. Epub 2013 Feb 12.
6
"Getting the dose right": facts, a blueprint, and encouragements.“精准给药”：事实、蓝图与鼓励
Clin Pharmacol Ther. 2007 Jul;82(1):12-4. doi: 10.1038/sj.clpt.6100215.
7
Role of Guidance and Policy in Enhancing the Impact of Clinical Pharmacology in Drug Development, Regulation, and Use.指导和政策在增强临床药理学在药物研发、监管和应用中的影响中的作用。
Clin Pharmacol Ther. 2020 Oct;108(4):710-715. doi: 10.1002/cpt.1849. Epub 2020 May 19.
8
Perspectives on the Current State of the Biosimilar Regulatory Pathway in the United States.美国生物类似药监管途径现状透视
Clin Pharmacol Ther. 2018 Jan;103(1):36-38. doi: 10.1002/cpt.909. Epub 2017 Nov 20.
9
Disease models.疾病模型。
Clin Adv Hematol Oncol. 2008 Apr;6(4):241-2.
10
2015 FDA drug approvals.2015年美国食品药品监督管理局批准的药物
Nat Rev Drug Discov. 2016 Feb;15(2):73-6. doi: 10.1038/nrd.2016.15.
引用本文的文献
1
Attitudes of health care professionals toward pharmacogenetic testing.医疗保健专业人员对药物遗传学检测的态度。
Mol Diagn Ther. 2011 Apr 1;15(2):115-22. doi: 10.1007/BF03256401.
2
Regulatory acceptance of toxicogenomics data.毒理基因组学数据的监管认可。
Environ Health Perspect. 2004 Aug;112(12):A663-4. doi: 10.1289/ehp.112-1277121.
Zotero 插件